Fitch's Double-Edged Upgrade: Bausch + Lomb Rises, But Junk Status Lingers

Fitch Ratings has delivered a positive signal to Bausch + Lomb Corp. and its parent company Bausch Health Cos., upgrading their credit grades. However, the rating agency has issued a clear caveat: the eye care unit's ratings will remain under scrutiny until the two companies complete their separation.
The upgrade comes with a strategic condition that highlights the importance of the planned corporate restructuring. Fitch is essentially sending a message that the credit improvement is contingent upon Bausch + Lomb successfully breaking away from its parent company, a move that could potentially unlock significant value and provide greater financial clarity.
By maintaining pressure on the ratings until the separation is finalized, Fitch is signaling its keen interest in seeing a clean, well-defined corporate structure that could enhance investor confidence and potentially improve the company's financial outlook.
The rating agency's stance underscores the critical nature of the planned corporate split and its potential implications for Bausch + Lomb's future financial performance and market positioning.